Understanding the immunological and genetic mechanisms shared by psoriasis and these associated dermatoses—such as Th1/Th17 pathway involvement and IL-17, IL-36, and other shared susceptibility loci—can improve diagnostic accuracy and guide therapeutic decisions. The gene discussed is IL17A; the disease is psoriasis.